S&P 500

5.351,33

-0,03%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

BNR

Burning Rock Biotech (BNR)

Burning Rock Biotech Ltd

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BNR

1 2 3 4 5 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
03/06/2024	12h08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
03/06/2024	06h41	GlobeNewswire Inc.	Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement	NASDAQ:BNR	Burning Rock Biotech Ltd
30/05/2024	09h42	GlobeNewswire Inc.	Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines	NASDAQ:BNR	Burning Rock Biotech Ltd
29/05/2024	12h05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
29/05/2024	07h34	GlobeNewswire Inc.	Burning Rock Reports First Quarter 2024 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
23/05/2024	08h00	GlobeNewswire Inc.	Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024	NASDAQ:BNR	Burning Rock Biotech Ltd
14/05/2024	12h06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
14/05/2024	08h02	GlobeNewswire Inc.	Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024	NASDAQ:BNR	Burning Rock Biotech Ltd
29/04/2024	09h30	GlobeNewswire Inc.	Burning Rock Publishes 2023 Annual Report on Form 20-F	NASDAQ:BNR	Burning Rock Biotech Ltd
26/04/2024	07h59	GlobeNewswire Inc.	Burning Rock Announces ADS Ratio Change	NASDAQ:BNR	Burning Rock Biotech Ltd
28/03/2024	22h16	GlobeNewswire Inc.	Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
14/02/2024	18h45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BNR	Burning Rock Biotech Ltd
10/01/2024	22h08	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BNR	Burning Rock Biotech Ltd
04/01/2024	12h01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
04/01/2024	07h03	GlobeNewswire Inc.	Burning Rock Announces Receipt of Notification from NASDAQ	NASDAQ:BNR	Burning Rock Biotech Ltd
20/12/2023	12h09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
20/12/2023	03h35	GlobeNewswire Inc.	Burning Rock Announces Results of 2023 Annual General Meeting	NASDAQ:BNR	Burning Rock Biotech Ltd
30/11/2023	12h08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
30/11/2023	07h25	GlobeNewswire Inc.	Burning Rock Reports Third Quarter 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
22/11/2023	12h08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
22/11/2023	08h04	GlobeNewswire Inc.	Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
21/11/2023	02h55	GlobeNewswire Inc.	Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
30/10/2023	08h20	GlobeNewswire Inc.	Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics	NASDAQ:BNR	Burning Rock Biotech Ltd
16/10/2023	01h18	GlobeNewswire Inc.	Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test	NASDAQ:BNR	Burning Rock Biotech Ltd
08/09/2023	04h43	GlobeNewswire Inc.	Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell	NASDAQ:BNR	Burning Rock Biotech Ltd
05/09/2023	12h09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
31/08/2023	07h30	GlobeNewswire Inc.	Burning Rock Reports Second Quarter 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
04/08/2023	09h27	GlobeNewswire Inc.	Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
28/06/2023	10h05	GlobeNewswire Inc.	Burning Rock Announces Resignation and Appointment of Directors	NASDAQ:BNR	Burning Rock Biotech Ltd
08/06/2023	06h20	GlobeNewswire Inc.	Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine	NASDAQ:BNR	Burning Rock Biotech Ltd